209 related articles for article (PubMed ID: 27095638)
1. From Child-Pugh to Model for End-Stage Liver Disease: Deciding Who Needs a Liver Transplant.
Reddy SS; Civan JM
Med Clin North Am; 2016 May; 100(3):449-64. PubMed ID: 27095638
[TBL] [Abstract][Full Text] [Related]
2. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
[TBL] [Abstract][Full Text] [Related]
3. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
4. [New scoring systems for severity outcome of liver cirrhosis and hepatocellular carcinoma: current issues concerning the Child-Turcotte-Pugh score and the Model of End-Stage Liver Disease (MELD) score].
Lee DH; Son JH; Kim TW
Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):167-79. PubMed ID: 14515034
[TBL] [Abstract][Full Text] [Related]
5. [General considerations, indications and contraindications for liver transplantation in Chile: a multicenter consensus development document].
Hepp J; Zapata R; Buckel E; Martínez J; Uribe M; Díaz JC; Ferrario M; Sanhueza E; Pérez RM; Hunter B; Ríos G; Humeres R; Poniachik J; Oksenberg D; Arrese M
Rev Med Chil; 2008 Jun; 136(6):793-804. PubMed ID: 18769839
[TBL] [Abstract][Full Text] [Related]
6. Liver transplant considerations for evaluation, CTP, and MELD.
Mathews SB; Allison W; Lin S
Crit Care Nurs Clin North Am; 2010 Sep; 22(3):403-11. PubMed ID: 20691390
[TBL] [Abstract][Full Text] [Related]
7. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma.
Marvin MR; Ferguson N; Cannon RM; Jones CM; Brock GN
Liver Transpl; 2015 May; 21(5):612-22. PubMed ID: 25694099
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation: from Child to MELD.
Gallegos-Orozco JF; Vargas HE
Med Clin North Am; 2009 Jul; 93(4):931-50, ix. PubMed ID: 19577123
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
10. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).
Adam R; Karam V; Delvart V; O'Grady J; Mirza D; Klempnauer J; Castaing D; Neuhaus P; Jamieson N; Salizzoni M; Pollard S; Lerut J; Paul A; Garcia-Valdecasas JC; Rodríguez FS; Burroughs A; ;
J Hepatol; 2012 Sep; 57(3):675-88. PubMed ID: 22609307
[No Abstract] [Full Text] [Related]
11. Advances in hepatology--transplantation, prognosis and imaging.
Kumar P
Br J Hosp Med; 1995 Feb 1-14; 53(3):68-9. PubMed ID: 7728318
[No Abstract] [Full Text] [Related]
12. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
[TBL] [Abstract][Full Text] [Related]
13. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
Wald C; Russo MW; Heimbach JK; Hussain HK; Pomfret EA; Bruix J
Radiology; 2013 Feb; 266(2):376-82. PubMed ID: 23362092
[No Abstract] [Full Text] [Related]
14. Liver transplantation in Spain.
de la Rosa G; Fondevila C; Navasa M
Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
[TBL] [Abstract][Full Text] [Related]
15. Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation.
Abbott-Johnson W; Kerlin P; Clague A; Johnson H; Cuneo R
J Gastroenterol Hepatol; 2011 Sep; 26(9):1402-10. PubMed ID: 21501225
[TBL] [Abstract][Full Text] [Related]
16. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
17. Top ten facts you need to know: about liver transplantation.
Butt FK; Earl TM; Anderson CD
J Miss State Med Assoc; 2014 Jul; 55(7):212-5. PubMed ID: 25252424
[No Abstract] [Full Text] [Related]
18. Anesthetic management in pediatric orthotopic liver transplant for fulminant hepatic failure and end-stage liver disease.
Camkıran A; Araz C; Seyhan Ballı S; Torgay A; Moray G; Pirat A; Arslan G; Haberal M
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():106-9. PubMed ID: 24635805
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
20. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
